Profile | GDS4284 / 229712_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 927 | 73 |
GSM687648 | Patient 402 control | 892.641 | 72 |
GSM687653 | Patient 403 control | 1040.78 | 75 |
GSM687658 | Patient 404 control | 899.734 | 72 |
GSM687663 | Patient 411 control | 775.483 | 70 |
GSM687668 | Patient 422 control | 968.436 | 73 |
GSM687673 | Patient 424 control | 973.123 | 73 |
GSM687678 | Patient 425 control | 731.29 | 69 |
GSM687683 | Patient 427 control | 1141.78 | 75 |
GSM687688 | Patient 428 control | 928.209 | 73 |
GSM687695 | Patient 441 control | 287.426 | 48 |
GSM687699 | Patient 443 control | 740.107 | 69 |
GSM687704 | Patient 444 control | 702.345 | 69 |
GSM687707 | Patient 448 control | 1607.7 | 81 |
GSM687712 | Patient 449 control | 1071.5 | 75 |
GSM687719 | Patient 450 control | 649.129 | 67 |
GSM687724 | Patient 451 control | 614.34 | 67 |
GSM687728 | Patient 452 control | 712.02 | 69 |
GSM687646 | Patient 401 treated 24h | 1194.36 | 76 |
GSM687649 | Patient 402 treated 24h | 961.687 | 73 |
GSM687665 | Patient 411 treated 24h | 797.968 | 70 |
GSM687651 | Patient 402 treated 4 weeks | 713.426 | 68 |
GSM687667 | Patient 411 treated 4 weeks | 1021.45 | 74 |
GSM687670 | Patient 422 treated 24h | 999.959 | 73 |
GSM687671 | Patient 422 treated 4 weeks | 1506.22 | 80 |
GSM687654 | Patient 403 treated 24h | 819.381 | 71 |
GSM687675 | Patient 424 treated 24h | 792.285 | 70 |
GSM687685 | Patient 427 treated 24h | 847.722 | 71 |
GSM687656 | Patient 403 treated 4 weeks | 869.925 | 72 |
GSM687677 | Patient 424 treated 4 weeks | 901.443 | 72 |
GSM687687 | Patient 427 treated 4 weeks | 1490.04 | 79 |
GSM687692 | Patient 428 treated 4h | 1191.78 | 76 |
GSM687716 | Patient 449 treated 4h | 786.137 | 71 |
GSM687722 | Patient 450 treated 4h | 700.799 | 68 |
GSM687680 | Patient 425 treated 24h | 847.349 | 71 |
GSM687690 | Patient 428 treated 24h | 950.091 | 74 |
GSM687700 | Patient 443 treated 24h | 508.762 | 61 |
GSM687705 | Patient 444 treated 24h | 494.973 | 64 |
GSM687714 | Patient 449 treated 24h | 850.347 | 72 |
GSM687721 | Patient 450 treated 24h | 842.041 | 71 |
GSM687682 | Patient 425 treated 4 weeks | 636.998 | 68 |
GSM687694 | Patient 428 treated 4 weeks | 1058.94 | 74 |
GSM687702 | Patient 443 treated 4 weeks | 762.012 | 69 |
GSM687718 | Patient 449 treated 4 weeks | 777.737 | 71 |
GSM687723 | Patient 450 treated 4 weeks | 848.178 | 71 |
GSM687661 | Patient 404 treated 4h | 1265.72 | 77 |
GSM687710 | Patient 448 treated 4h | 797.394 | 71 |
GSM687726 | Patient 451 treated 4h | 902.24 | 72 |
GSM687730 | Patient 452 treated 4h | 365.227 | 46 |
GSM687660 | Patient 404 treated 24h | 414.565 | 60 |
GSM687697 | Patient 441 treated 24h | 379.53 | 56 |
GSM687709 | Patient 448 treated 24h | 1200.94 | 77 |
GSM687725 | Patient 451 treated 24h | 897.55 | 72 |
GSM687729 | Patient 452 treated 24h | 532.045 | 65 |
GSM687727 | Patient 451 treated 4 weeks | 739.475 | 69 |
GSM687731 | Patient 452 treated 4 weeks | 694.326 | 68 |